During the past decade, Ashley Salazar conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ashley Salazar" are "Anemia, Iron Deficiency" (1 trials), "Cesarean Section Complications" (1 trials), "Delivery Complication" (1 trials), "Insulin Resistance, Diabetes" (1 trials) and "Satisfaction" (1 trials). Many other conditions were trialed in "Ashley Salazar" in a lesser frequency.

Most popular intervention types in "Ashley Salazar" are "Combination Product" (1 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ferrous sulfate" (1 trials), "HOMA IR the standard testing for insulin resistance" (1 trials), "Iron dextran" (1 trials), "Quantose IR and Quantose IGT analysis" (1 trials) and "ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ashley Salazar" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ashley Salazar". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ashley Salazar, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ashley Salazar, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".